These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 6125074)

  • 21. [The effect of the beta 1 selective beta blocker, betaxolol, on metabolism in type II diabetics].
    Janka HU; Ziegler AG; Larrat V; Mehnert H
    Arzneimittelforschung; 1989 May; 39(5):615-7. PubMed ID: 2569309
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of environmental temperature and humidity on bronchial responses during assessment of selectivity of beta-adrenoceptor antagonists in man.
    Taylor EA; Trembath PW; Warrington SJ
    Br J Clin Pharmacol; 1981 Aug; 12(2):201-9. PubMed ID: 6118171
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A dose-ranging study to evaluate the beta-adrenoceptor selectivity of single doses of betaxolol.
    Irvine NA; Lipworth BJ; McDevitt DG
    Br J Clin Pharmacol; 1990 Jul; 30(1):119-26. PubMed ID: 1975196
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacodynamic studies in man of the beta-adrenoceptor antagonist DL 071 IT.
    Radice M; Amanzio R; Criscuolo D
    Eur J Clin Pharmacol; 1979 Sep; 16(2):87-90. PubMed ID: 40801
    [TBL] [Abstract][Full Text] [Related]  

  • 25. What is the real pharmacological rationale for beta-receptor blocking agents?
    Biamino G; Schröder R
    Eur Heart J; 1983 Jul; 4 Suppl D():137-41. PubMed ID: 6137373
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of the centrally acting agent clonidine on circulating catecholamines at rest and during exercise. Comparison with the effects of beta-blocking agents.
    Mäurer W; Hausen M; Krämer B; Kübler W
    Chest; 1983 Feb; 83(2 Suppl):366-9. PubMed ID: 6129951
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiovascular effects of befunolol, betaxolol and timolol eye drops.
    Dorigo MT; Cerin O; Fracasso G; Altafini R
    Int J Clin Pharmacol Res; 1990; 10(3):163-6. PubMed ID: 1977708
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of cimetidine on the pharmacokinetics of the new beta-blocker betaxolol.
    Rey E; Jammet P; d'Athis P; de Lauture D; Christoforov B; Weber S; Olive G
    Arzneimittelforschung; 1987 Aug; 37(8):953-6. PubMed ID: 2890358
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dose-effect relationship and safety of oral administration of penbutolol. A new beta adrenoceptor antagonist in normal subjects.
    Sharma PL; Sapru RP
    Int J Clin Pharmacol Biopharm; 1978 Mar; 16(3):98-101. PubMed ID: 25846
    [No Abstract]   [Full Text] [Related]  

  • 30. [Effect of different beta-receptor blockers on the respiratory function of patients with chronic obstructive pulmonary disease and arterial hypertension].
    Dorow P
    Arzneimittelforschung; 1987 Dec; 37(12):1370-2. PubMed ID: 2896506
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exercise during therapeutic beta-blockade: a two-year study in hypertensive patients.
    Frisk-Holmberg M; Ström G
    Clin Pharmacol Ther; 1986 Oct; 40(4):395-9. PubMed ID: 3757402
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reduction of beta-adrenergic receptors by tertatolol: an additional mechanism for beta-adrenergic blockade.
    De Blasi A; Lipartiti M; Pirone F; Rochat C; Prost JF; Garattini S
    Clin Pharmacol Ther; 1986 Mar; 39(3):245-54. PubMed ID: 2868822
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of beta-blocking activity of trimepranol in man.
    Pentikäinen PJ; Neuvonen PJ; Penttilä A
    Int J Clin Pharmacol Biopharm; 1978 Jun; 16(6):279-84. PubMed ID: 27464
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparative study of the activity of beta-adrenoceptor antagonists in man.
    Taylor SH; Thadani U; Davidson C; singleton W; Myint S
    Int J Clin Pharmacol Biopharm; 1975 Jul; 12(1-2):305-6. PubMed ID: 240783
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of a single oral administration of Epanolol on exercise tolerance in patients with stable effort angina pectoris.
    Vandenbosch H; Piessens J; De Geest H
    Acta Cardiol; 1991; 46(1):11-25. PubMed ID: 1674394
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of nipradilol, a new beta-blocking agent with vasodilating properties, on exercise tolerance in patients with stable effort angina: a double-blind study.
    Araki H; Hayata N; Nakamura M
    Clin Ther; 1987; 9(6):656-62. PubMed ID: 2894246
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dose related efficacy of betaxolol in combination with nitroglycerin in patients with angina pectoris: a double blind cross-over study.
    Stroobandt R; Kesteloot H
    Arch Int Pharmacodyn Ther; 1984 Feb; 267(2):299-309. PubMed ID: 6143538
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stereoselective effects of (R)- and (S)-carvedilol in humans.
    Stoschitzky K; Koshucharova G; Lercher P; Maier R; Sakotnik A; Klein W; Liebmann PM; Lindner W
    Chirality; 2001 Jul; 13(7):342-6. PubMed ID: 11400186
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Long term comparison between atenolol and a depot form of propranolol hydrochloride on the heart rate and blood pressure at rest and during physical work in normal subjects].
    Wink K; Weisser P
    Arzneimittelforschung; 1980; 30(8):1298-301. PubMed ID: 7192146
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiovascular and pulmonary effects of beta-blocking agents: implications for their use in ophthalmology.
    Collignon P
    Surv Ophthalmol; 1989 Apr; 33 Suppl():455-6; discussion 459-60. PubMed ID: 2568697
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.